Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.91 M3.06 M3.02 M3.47 M3.19 M 12.74 M Research & development ————— — Operating income 16.07 M16.34 M18.08 M15.64 M17.91 M 67.97 M Non-Operating Income, Total 341 K349 K452 K361 K539 K 1.7 M Interest expense, net of interest capitalized 13.25 M13.27 M13.7 M8.17 M7.64 M 42.77 M Non-Operating Income, excl. Interest Expenses -12.9 M-12.92 M-13.25 M-7.8 M-7.1 M -41.07 M Unusual income/expense ————— — Pretax income 7.7 M7.96 M9.24 M7.63 M8.84 M 33.68 M Equity in earnings ————— — Taxes 1.89 M1.98 M2.29 M1.86 M2.18 M 8.3 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 5.81 M5.98 M6.95 M5.78 M6.66 M 25.37 M Discontinued operations ————— — Net income 5.81 M5.98 M6.95 M5.78 M6.66 M 25.37 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 5.81 M5.98 M6.95 M5.78 M6.66 M 25.37 M Basic earnings per share (Basic EPS) 0.90.921.070.891.03 3.91 Diluted earnings per share (Diluted EPS) 0.890.921.070.891.03 3.91 Average basic shares outstanding 6.47 M6.49 M6.5 M6.49 M6.48 M — Diluted shares outstanding 6.49 M6.51 M6.51 M6.5 M6.49 M — EBITDA 8.76 M8.99 M10.59 M8.41 M10.96 M 38.95 M EBIT 8.02 M8.18 M9.72 M7.48 M10.28 M 35.65 M Cost of revenue 656 K860 K510 K717 K879 K 2.97 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 738 K819 K871 K937 K682 K 3.31 M